Literature DB >> 31567302

Retention of Alzheimer Disease Research Participants.

Joshua D Grill1,2,3,4, Jimmy Kwon5, Merilee A Teylan6, Aimee Pierce7, Eric D Vidoni8, Jeffrey M Burns8, Allison Lindauer7, Joseph Quinn7, Jeff Kaye7, Daniel L Gillen1,5, Bin Nan1,5.   

Abstract

INTRODUCTION: Participant retention is important to maintaining statistical power, minimizing bias, and preventing scientific error in Alzheimer disease and related dementias research.
METHODS: We surveyed representative investigators from NIH-funded Alzheimer's Disease Research Centers (ADRC), querying their use of retention tactics across 12 strategies. We compared survey results to data from the National Alzheimer's Coordinating Center for each center. We used a generalized estimating equation with independent working covariance model and empirical standard errors to assess relationships between survey results and rates of retention, controlling for participant characteristics.
RESULTS: Twenty-five (83%) responding ADRCs employed an average 42 (SD=7) retention tactics. In a multivariable model that accounted for participant characteristics, the number of retention tactics used by a center was associated with participant retention (odds ratio=1.68, 95% confidence interval: 1.42, 1.98; P<0.001 for the middle compared with the lowest tertile survey scores; odds ratio=1.59, 95% confidence interval: 1.30, 1.94; P<0.001 for the highest compared with the lowest tertile survey scores) at the first follow-up visit. Participant characteristics such as normal cognition diagnosis, older age, higher education, and Caucasian race were also associated with higher retention.
CONCLUSIONS: Retention in clinical research is more likely to be achieved by employing a variety of tactics.

Entities:  

Year:  2019        PMID: 31567302      PMCID: PMC6878201          DOI: 10.1097/WAD.0000000000000353

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  27 in total

1.  Recruitment, retention and other methodological issues related to clinical trials for Alzheimer's disease.

Authors:  B Vellas
Journal:  J Nutr Health Aging       Date:  2012-04       Impact factor: 4.075

2.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

Review 3.  Lost in a jungle of evidence: we need a compass.

Authors:  Jacqueline French; Gary Gronseth
Journal:  Neurology       Date:  2008-11-11       Impact factor: 9.910

4.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

5.  Challenging Assumptions About African American Participation in Alzheimer Disease Trials.

Authors:  Richard E Kennedy; Gary R Cutter; Guoqiao Wang; Lon S Schneider
Journal:  Am J Geriatr Psychiatry       Date:  2017-04-25       Impact factor: 4.105

6.  Alzheimer's disease therapeutic trials: EU/US Task Force report on recruitment, retention, and methodology.

Authors:  B Vellas; H Hampel; M E Rougé-Bugat; M Grundman; S Andrieu; S Abu-Shakra; R Bateman; R Berman; R Black; M Carrillo; M Donohue; M Mintun; J Morris; R Petersen; R G Thomas; J Suhy; L Schneider; L Seely; P Tariot; J Touchon; M Weiner; C Sampaio; P Aisen
Journal:  J Nutr Health Aging       Date:  2012-04       Impact factor: 4.075

Review 7.  Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association.

Authors:  Keith A Johnson; Satoshi Minoshima; Nicolaas I Bohnen; Kevin J Donohoe; Norman L Foster; Peter Herscovitch; Jason H Karlawish; Christopher C Rowe; Maria C Carrillo; Dean M Hartley; Saima Hedrick; Virginia Pappas; William H Thies
Journal:  J Nucl Med       Date:  2013-01-28       Impact factor: 10.057

Review 8.  Systematic review identifies number of strategies important for retaining study participants.

Authors:  Karen A Robinson; Cheryl R Dennison; Dawn M Wayman; Peter J Pronovost; Dale M Needham
Journal:  J Clin Epidemiol       Date:  2007-05-10       Impact factor: 6.437

9.  Discontinuation and non-publication of randomised clinical trials supported by the main public funding body in Switzerland: a retrospective cohort study.

Authors:  Alain Amstutz; Stefan Schandelmaier; Roy Frei; Jakub Surina; Arnav Agarwal; Kelechi Kalu Olu; Reem Alturki; Belinda Von Niederhäusern; Erik Von Elm; Matthias Briel
Journal:  BMJ Open       Date:  2017-08-01       Impact factor: 2.692

Review 10.  Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set.

Authors:  Lilah Besser; Walter Kukull; David S Knopman; Helena Chui; Douglas Galasko; Sandra Weintraub; Gregory Jicha; Cynthia Carlsson; Jeffrey Burns; Joseph Quinn; Robert A Sweet; Katya Rascovsky; Merilee Teylan; Duane Beekly; George Thomas; Mark Bollenbeck; Sarah Monsell; Charles Mock; Xiao Hua Zhou; Nicole Thomas; Elizabeth Robichaud; Margaret Dean; Janene Hubbard; Mary Jacka; Kristen Schwabe-Fry; Joylee Wu; Creighton Phelps; John C Morris
Journal:  Alzheimer Dis Assoc Disord       Date:  2018 Oct-Dec       Impact factor: 2.703

View more
  8 in total

1.  Research Attitudes Questionnaire scores predict Alzheimer's disease clinical trial dropout.

Authors:  Shana D Stites; R Scott Turner; Jeanine Gill; Anna Gurian; Jason Karlawish; Joshua D Grill
Journal:  Clin Trials       Date:  2021-01-10       Impact factor: 2.486

2.  Screening and enrollment of underrepresented ethnocultural and educational populations in the Alzheimer's Disease Neuroimaging Initiative (ADNI).

Authors:  Miriam T Ashford; Rema Raman; Garrett Miller; Michael C Donohue; Ozioma C Okonkwo; Monica Rivera Mindt; Rachel L Nosheny; Godfrey A Coker; Ronald C Petersen; Paul S Aisen; Michael W Weiner
Journal:  Alzheimers Dement       Date:  2022-02-25       Impact factor: 16.655

3.  Strategies Associated with Retaining Participants in the Longitudinal National Alzheimer's Coordinating Center Uniform Data Set Study.

Authors:  Christian R Salazar; Marina Ritchie; Daniel L Gillen; Joshua D Grill
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

4.  Effects of sex, race, ethnicity, and education on online aging research participation.

Authors:  Miriam T Ashford; Joseph Eichenbaum; Tirzah Williams; Monica R Camacho; Juliet Fockler; Aaron Ulbricht; Derek Flenniken; Diana Truran; R Scott Mackin; Michael W Weiner; Rachel L Nosheny
Journal:  Alzheimers Dement (N Y)       Date:  2020-05-26

5.  Disclosure of individual research results at federally funded Alzheimer's Disease Research Centers.

Authors:  J Scott Roberts; Rebecca Ferber; Deborah Blacker; Malia Rumbaugh; Joshua D Grill
Journal:  Alzheimers Dement (N Y)       Date:  2021-10-14

6.  Experiences of Participation in a Multimodal Preventive Trial MIND-ADMINI Among Persons with Prodromal Alzheimer's Disease: A Qualitative Study.

Authors:  Ulrika Akenine; Charlotta Thunborg; Miia Kivipelto; Mandana Fallahpour
Journal:  J Multidiscip Healthc       Date:  2022-01-29

Review 7.  Behavioral Change Factors and Retention in Web-Based Interventions for Informal Caregivers of People Living With Dementia: Scoping Review.

Authors:  Kuan-Ching Wu; Yan Su; Frances Chu; Annie T Chen; Oleg Zaslavsky
Journal:  J Med Internet Res       Date:  2022-07-07       Impact factor: 7.076

8.  Development and implementation of an electronic Clinical Dementia Rating and Financial Capacity Instrument-Short Form.

Authors:  Taylor Howell; Shilpa Gummadi; Chau Bui; Jessica Santhakumar; Kristen Knight; Erik D Roberson; Daniel Marson; Carol Chambless; Adam Gersteneker; Roy Martin; Richard Kennedy; Yue Zhang; John C Morris; Krista L Moulder; Connie Mayo; Maria Carroll; Yan Li; Ronald C Petersen; Nikki H Stricker; Rachel L Nosheny; Scott Mackin; Michael W Weiner
Journal:  Alzheimers Dement (Amst)       Date:  2022-07-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.